12 results
DEFA14A
EX-2.1
udhafnul
30 Nov 23
Additional proxy soliciting materials
4:07pm
8-K
EX-2.1
ihsnid1txtzecfzhdbx
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
PREM14A
7k2i4hkf1m
21 Dec 23
Preliminary proxy related to merger
4:52pm
DEFM14A
qoxvv977rl3i
2 Jan 24
Proxy related to merger
4:26pm
- Prev
- 1
- Next